Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Assure Holdings Corp. (IONM : NSDQ)
 
 • Company Description   
Assure Holdings Corp. works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services which support intraoperative neuromonitoring activities during invasive surgeries. Assure Holdings Corp. is based in DENVER.

Number of Employees: 134

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.18 Daily Weekly Monthly
20 Day Moving Average: 11,893 shares
Shares Outstanding: 12.92 (millions)
Market Capitalization: $28.17 (millions)
Beta: 1.44
52 Week High: $8.15
52 Week Low: $1.09
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -52.61% -50.16%
12 Week -56.75% -52.31%
Year To Date -59.63% -51.64%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
7887 EAST BELLEVIEW AVENUE SUITE 500
-
ENGLEWOOD,CO 80111
USA
ph: 720-287-3093
fax: -
ir@assureiom.com http://www.assureneuromonitoring.com
 
 • General Corporate Information   
Officers
John Farlinger - Chief Executive Officer and Executive Chairman
John Price - Chief Financial Officer
Preston Parsons - Director
Christopher Rumana - Director
Steven Summer - Director

Peer Information
Assure Holdings Corp. (CHCR)
Assure Holdings Corp. (ESRX)
Assure Holdings Corp. (MYDP)
Assure Holdings Corp. (GBCS)
Assure Holdings Corp. (LAXAF)
Assure Holdings Corp. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 04625J204
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/15/22
Share - Related Items
Shares Outstanding: 12.92
Most Recent Split Date: 9.00 (0.20:1)
Beta: 1.44
Market Capitalization: $28.17 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.20 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.37 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 20.00% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/15/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.05
Price/Cash Flow: -
Price / Sales: 0.97
EPS Growth
vs. Year Ago Period: -90.00%
vs. Previous Quarter: -533.33%
Sales Growth
vs. Year Ago Period: -1.34%
vs. Previous Quarter: -51.33%
ROE
03/31/22 - -15.43
12/31/21 - -11.57
09/30/21 - -13.77
ROA
03/31/22 - -9.26
12/31/21 - -6.82
09/30/21 - -8.03
Current Ratio
03/31/22 - 9.33
12/31/21 - 10.22
09/30/21 - 9.98
Quick Ratio
03/31/22 - 9.33
12/31/21 - 10.22
09/30/21 - 9.98
Operating Margin
03/31/22 - -13.68
12/31/21 - -9.44
09/30/21 - -11.55
Net Margin
03/31/22 - -13.68
12/31/21 - -9.44
09/30/21 - -11.55
Pre-Tax Margin
03/31/22 - -16.22
12/31/21 - -12.28
09/30/21 - -12.96
Book Value
03/31/22 - 2.08
12/31/21 - 2.24
09/30/21 - 2.05
Inventory Turnover
03/31/22 - -
12/31/21 - -
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.47
12/31/21 - 0.47
09/30/21 - 0.45
Debt-to-Capital
03/31/22 - 31.99
12/31/21 - 32.00
09/30/21 - 31.22
 

Powered by Zacks Investment Research ©